Literature DB >> 21572339

Defective neuromuscular junction organization and postnatal myogenesis in mice with severe spinal muscular atrophy.

Elisabet Dachs1, Marta Hereu, Lídia Piedrafita, Anna Casanovas, Jordi Calderó, Josep E Esquerda.   

Abstract

A detailed pathologic analysis was performed on Smn(-/-);SMN2 mice as a mouse model for human type I spinal muscular atrophy (SMA). We provide new data concerning changes in the spinal cord, neuromuscular junctions and muscle cells, and in the organs of the immune system. The expression of 10 synaptic proteins was analyzed in 3-dimensionally reconstructed neuromuscular junctions by confocal microscopy. In addition to defects in postsynaptic occupancy, there was a marked reduction in calcitonin gene-related peptide and Rab3A in the presynaptic motor terminals of some, but not all, of the skeletal muscles analyzed. Defects in the organization of presynaptic nerve terminals were also detected by electron microscopy. Moreover, degenerative changes in muscle cells, defective postnatal muscle growth, and prominent muscle satellite cell apoptosis were also observed. All of these changes occurred in the absence of massive loss of spinal cord motoneurons. On the other hand, astroglia, but not microglia, increased in the ventral horn of newborn SMA mice. In skeletal muscles, the density of interstitial macrophages was significantly reduced, and monocyte chemotactic protein-1 was downregulated. These findings raise questions regarding the primary contribution of a muscle cell defect to the SMA phenotype.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21572339     DOI: 10.1097/NEN.0b013e31821cbd8b

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  36 in total

1.  Survival motor neuron protein in motor neurons determines synaptic integrity in spinal muscular atrophy.

Authors:  Tara L Martinez; Lingling Kong; Xueyong Wang; Melissa A Osborne; Melissa E Crowder; James P Van Meerbeke; Xixi Xu; Crystal Davis; Joe Wooley; David J Goldhamer; Cathleen M Lutz; Mark M Rich; Charlotte J Sumner
Journal:  J Neurosci       Date:  2012-06-20       Impact factor: 6.167

2.  Spinal muscular atrophy astrocytes exhibit abnormal calcium regulation and reduced growth factor production.

Authors:  Jered V McGivern; Teresa N Patitucci; Joshua A Nord; Marie-Elizabeth A Barabas; Cheryl L Stucky; Allison D Ebert
Journal:  Glia       Date:  2013-07-10       Impact factor: 7.452

3.  SMN deficiency negatively impacts red pulp macrophages and spleen development in mouse models of spinal muscular atrophy.

Authors:  Marie-Therese Khairallah; Jacob Astroski; Sarah K Custer; Elliot J Androphy; Craig L Franklin; Christian L Lorson
Journal:  Hum Mol Genet       Date:  2017-03-01       Impact factor: 6.150

4.  Copy number variations in 6q14.1 and 5q13.2 are associated with alcohol dependence.

Authors:  Peng Lin; Sarah M Hartz; Jen-Chyong Wang; Arpana Agrawal; Tian-Xiao Zhang; Nicholas McKenna; Kathleen Bucholz; Andrew I Brooks; Jay A Tischfield; Howard J Edenberg; Victor M Hesselbrock; John R Kramer; Samuel Kuperman; Marc A Schuckit; Alison M Goate; Laura J Bierut; John P Rice
Journal:  Alcohol Clin Exp Res       Date:  2012-06-15       Impact factor: 3.455

5.  Genome-wide analysis shows association of epigenetic changes in regulators of Rab and Rho GTPases with spinal muscular atrophy severity.

Authors:  Galina Y Zheleznyakova; Sarah Voisin; Anton V Kiselev; Markus Sällman Almén; Miguel J Xavier; Marianna A Maretina; Lyudmila I Tishchenko; Robert Fredriksson; Vladislav S Baranov; Helgi B Schiöth
Journal:  Eur J Hum Genet       Date:  2013-01-09       Impact factor: 4.246

Review 6.  Is spinal muscular atrophy a disease of the motor neurons only: pathogenesis and therapeutic implications?

Authors:  Chiara Simone; Agnese Ramirez; Monica Bucchia; Paola Rinchetti; Hardy Rideout; Dimitra Papadimitriou; Diane B Re; Stefania Corti
Journal:  Cell Mol Life Sci       Date:  2015-12-18       Impact factor: 9.261

Review 7.  Mechanistic principles of antisense targets for the treatment of spinal muscular atrophy.

Authors:  Natalia N Singh; Brian M Lee; Christine J DiDonato; Ravindra N Singh
Journal:  Future Med Chem       Date:  2015-09-18       Impact factor: 3.808

8.  Astrocytes influence the severity of spinal muscular atrophy.

Authors:  Hansjörg Rindt; Zhihua Feng; Chiara Mazzasette; Jacqueline J Glascock; David Valdivia; Noah Pyles; Thomas O Crawford; Kathryn J Swoboda; Teresa N Patitucci; Allison D Ebert; Charlotte J Sumner; Chien-Ping Ko; Christian L Lorson
Journal:  Hum Mol Genet       Date:  2015-04-24       Impact factor: 6.150

9.  Behavioral and electrophysiological outcomes of tissue-specific Smn knockdown in Drosophila melanogaster.

Authors:  Christina Timmerman; Subhabrata Sanyal
Journal:  Brain Res       Date:  2012-10-26       Impact factor: 3.252

10.  The DcpS inhibitor RG3039 improves motor function in SMA mice.

Authors:  James P Van Meerbeke; Rebecca M Gibbs; Heather L Plasterer; Wenyan Miao; Zhihua Feng; Ming-Yi Lin; Agnieszka A Rucki; Claribel D Wee; Bing Xia; Shefali Sharma; Vincent Jacques; Darrick K Li; Livio Pellizzoni; James R Rusche; Chien-Ping Ko; Charlotte J Sumner
Journal:  Hum Mol Genet       Date:  2013-05-31       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.